Proquin XR Approval History
- FDA approved: Yes (First approved May 19th, 2005)
- Brand name: Proquin XR
- Generic name: ciprofloxacin
- Dosage form: Extended-Release Tablets
- Company: Depomed, Inc.
- Treatment for: Urinary Tract Infection
Proquin XR (ciprofloxacin) is an extended release fluoroquinolone antibiotic indicated for the treatment of urinary tract infections.
Development History and FDA Approval Process for Proquin XR
|May 19, 2005||Proquin XR Depomed, Inc. - Treatment for Uncomplicated Urinary Tract Infections|
|Sep 20, 2004||Depomed Announces Proquin XR NDA Accepted by FDA|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.